HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$16.80 USD
-0.05 (-0.30%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $16.82 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 30% (80 out of 252)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.69 | 9.99 |
Current Quarter Estimate | NA | 5.41 | 59.00 |
Year Ago Quarter Estimate | NA | -1.55 | 50.37 |
Next Quarter Estimate | NA | 5.88 | 60.00 |
Next Year Estimate | 0.63 | 39.92 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -182.76 | 12.70 | 26.94 |
Next Year | 231.25 | 10.10 | 8.00 |
Last 5 Years | NA | 1.00 | 9.00 |
Next 5 Years | NA | 20.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 3.95 | 2.24 |
Price/Cash Flow (MRFY) | 26.94 | 14.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -160.91% |
Return on Equity (TTM) | NA | -52.31% |
Debt to Equity (MRQ) | 0.06 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.